Infinium Global Research Biosimilar Market | Page 4

various diseases in countries such as China, India, South Korea and others drive the growth of biosimilar market in Asia-
Pacific. As the rate of approvals for biosimilars are increasing at a faster pace in the U.S., the North-American region is
expected to become the fastest growing biosimilar market during the forecast period. The pharmaceutical companies in the
North American region are expected to make use of the research and development initiatives related to biosimilars and
expiring biologics patents for increasing the production of biosimilar medicine to meet the requirements of the geriatric
population and the patients with chronic illnesses depending upon the reimbursement and insurance policies.
Companies Profiled:
Allergan plc,
BIOCAD,
Biocon,
BioXpress Therapeutics SA,
Boehringer Ingelheim GmbH,
Celltrion Inc.,
Coherus BioSciences, Inc,
Dr. Reddy’s Laboratories Ltd.,
Genor BioPharma Co. Ltd,
Intas Pharmaceuticals Limited,
Novartis AG,
Infinium Global Research